Search for: "In re Pattern Energy Group Inc. Securities Class Action"
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
14 Feb 2018, 2:57 pm
In re Lehman Brothers Securities & ERISA Litigation, 655 F. [read post]
27 Jan 2012, 2:21 pm
The other concern is that greater compensation for the RP would risk creating “plaintiff mills” such that lead to Private Securities Litigation Reform Act by the US Congress.[9] The experience of criminal convictions for some of the top class actions lawyers in the US indicates the potential for corruption. [read post]
November 30, 2009 – Environmental Law Settlements, Decisions, Regulatory Actions and Lawsuit Filings
30 Nov 2009, 9:25 am
The lawsuit seeks damages from a group of 33 energy companies, including ExxonMobil and coal giant Peabody Energy, electric utilities, and other conglomerates for allegedly emitting greenhouse gases that the litigants say contributed to global warming. . . [read post]
14 Apr 2010, 6:25 am
, In re The TJX Companies, Inc., FTC Docket No. [read post]
23 Mar 2023, 5:31 am
District Court in TikTok Inc. et al. v. [read post]
10 Sep 2007, 1:02 am
The ruling touches on an issue important to many companies: arbitration agreements containing class action waivers. [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from MHLW-Japan:… [read post]
20 Jun 2018, 5:00 pm
He filed a putative class action, which the district court initially granted, but then decertified. [read post]
